ISO 24651:2022

Biotechnology — Biobanking — Requirements for human mesenchymal stromal cells derived from bone marrow

Publication date:   Aug 1, 2022

General information

60.60 Standard published   Aug 1, 2022

ISO

ISO/TC 276 Biotechnology

International Standard

07.080   Biology. Botany. Zoology

Buying

  Published

PDF - €182.71

  English  



Buy

Scope

This document specifies requirements for the biobanking of human mesenchymal stromal cells derived from bone marrow (hBM-MSCs), including the collection of bone marrow and associated data, isolation, culture, characterization, quality control, cryopreservation, storage, thawing, disposal, distribution and transport.
This document is applicable to all organizations performing biobanking with hBM-MSCs used for research.
This document does not apply to hBM-MSCs for the purpose of in vivo application in humans, cell therapy, clinical applications, tissue engineering or therapeutic use.
NOTE      International, national or regional regulations or requirements, or multiple of them, can also apply to specific topics covered in this document.

Life cycle

NOW

PUBLISHED
ISO 24651:2022
60.60 Standard published
Aug 1, 2022